| ||||||
Enter here for the best oncologist referral service available anywhere. Use our service to search for and find the best oncologists to help you win your battle against cancer. We can set you up with the best oncologist anywhere. Look here Genentech and Novartis are developing an anti-IgE monoclonal antibody for asthma and allergic rhinitis. In December 1999 they announced positive study results. This is evidence that reducing IgE results in a reduction of symptoms associated with IgE-mediated allergic disease.13 For people who find they cannot adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, and cromolyn sodium - any of which can be used alone or in combination. Many effective antihistamines and decongestants also are available without a prescription. Click here for allergy medication online. Topical nasal steroids Topical nasal steroids are anti-inflammatory drugs that stop the allergic reaction. In addition to other beneficial actions, they reduce the number of mast cells in the nose and reduce mucus secretion and nasal swelling. The combination of antihistamines and nasal steroids is a very effective way to treat allergic rhinitis. This medication should not be confused with anabolic steroids that have serious side effects. Cromolyn sodium Cromolyn sodium stops allergic reactions from starting. It is administered as a nasal spray, and it can prevent the release of chemicals like histamine from the mast cell. Click here for allergy medication online. In 1992 in El Paso, TX a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7 | ||||||
© Copyright 2003. www.oncologist-referral.com. All Rights Reserved |
breast cancer oncology result, breast cancer oncology results, breastcanceroncologyresult, breastcanceroncologyresults, cancer care, cancer center, cancer center search, cancer centers, cancer clinic, cancer clinics, cancercare, cancercenter, cancercenters, cancercentersearch, cancerclinic, cancerclinics, cancers, carcinoid lung cancer, carcinoidlungcancer, cervic cancer, cervical cancer, cervical cancers, cervicalcancer, cervicalcancers, cerviccancer, cervix cancer, cervixcancer, clinical oncology, clinicaloncology, colin cancer, colincancer, colon cancer, coloncancer, large cell lymphoma, largecelllymphoma, leukemia, leukemia & lymphoma society, leukemia and lymphoma, leukemia cancer, leukemia&lymphomasociety, leukemiaandlymphoma, leukemiacancer, lung cancer diagnosis, lung cancer news, lung cancer patient, lung cancer patients, lungcancerdiagnosis, lungcancernews, lungcancerpatient, lungcancerpatients, lymph cancer, lymphatic cancer, lymphaticcancer, lymphcancer, lymphoma, lymphoma cancer, lymphoma information, lymphoma information network, lymphomacancer, lymphomainformation, lymphomainformationnetwork, medical oncology, medicaloncology, mestatic breast cancer, mestaticbreastcancer, metastatic breast cancer, metastatic cervical cancer, metastatic colorectal cancer, metastatic melanoma, metastatic prostate cancer, metastaticbreastcancer, metastaticcervicalcancer, metastaticcolorectalcancer, metastaticmelanoma, metastaticprostatecancer, metastic breast cancer, metasticbreastcancer, metasticized breast cancer, metasticizedbreastcancer, mouth cancer, mouthcancer, multiple melanoma, multiple myeloma, multiple myeloma cancer, multiplemelanoma, multiplemyeloma, multiplemyelomacancer, myeloid leukemia, myeloidleukemia, natural cancer cure breast, naturalcancercurebreast, neck cancer, neckcancer, oncology, oncology radiation therapies, oncology radiation therapy, oncology research, oncology treatment, oncology treatments, oncologyradiationtherapies, oncologyradiationtherapy, oncologyresearch, oncologytreatment, oncologytreatments, pancreatic cancer specialist, pancreatic cancer specialists, pancreaticcancerspecialist, pancreaticcancerspecialists, prostate cancer diagnosis, prostate cancer information, prostate cancer pathology, prostate cancer prevention, prostate cancer screening, prostatecancerdiagnosis, prostatecancerinformation, prostatecancerpathology, prostatecancerprevention, prostatecancerscreening, skin melanoma, skinmelanoma, small cell cancer, small cell lung cancer, smallcellcancer, smallcelllungcancer, spinal cancer, spinalcancer, st57, stage 3 ovarian cancer, stage four ovarian cancer, stage3ovariancancer, stagefourovariancancer, stages of breast cancer, stages of lung cancer, stages of melanoma, stagesofbreastcancer, stagesoflungcancer, stagesofmelanoma, stomach cancer, stomachcancer, testical cancer, testicalcancer, testicle cancer, testiclecancer